With IDO, we explored a catabolic enzyme that when overexpressed by cancer cells can starve the microenvironment of the essential amino acid tryptophane and release immunosuppressive metabolites, like l-kynurenine or 3-hydroxykynurenine, which can tolerize T cells [22, 23]. Here, IDO1 is linked to cancer.